These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 12404879)

  • 1. Synthesis and beta 1-, beta 2-adrenergic receptor binding studies of 4-acylamino-substituted phenoxypropanolamine and 5-acylamino-substituted naphthyloxypropanolamine derivatives.
    Jindal DP; Coumar MS; Bruni G; Massarelli P
    Arzneimittelforschung; 2002; 52(9):654-63. PubMed ID: 12404879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different sensitivity of beta 1- and beta 2-adrenergic receptors towards cyanogen bromide.
    Severne Y; Vauquelin G
    Arch Int Pharmacodyn Ther; 1988; 292():122-30. PubMed ID: 2840038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization.
    Wessels MR; Mullikin D; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):10-20. PubMed ID: 39240
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro measurement of the beta-adrenergic blocking properties of ORF 12592, the 5-hydroxy analog of propranolol.
    Greenslade FC; Newquist KL
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):270-80. PubMed ID: 28704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, beta-adrenergic blocking activity and beta-receptor binding affinities of 1-substituted-3-(2-isopropyl-5-methyl-phenoxy)-propan-2-ol oxalates.
    Jindal DP; Coumar MS; Nandakumar K; Bodhankar SL; Purohit PG; Mahadik KR; Bruni G; Collavoli E; Massarelli P
    Farmaco; 2003 Aug; 58(8):557-62. PubMed ID: 12875885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
    Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
    J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the receptor profile of bisoprolol.
    Klockow M; Greiner HE; Haase A; Schmitges CJ; Seyfried C
    Arzneimittelforschung; 1986 Feb; 36(2):197-200. PubMed ID: 2870719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
    Ahmed M; Hanaoka Y; Nagatomo T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of the turkey erythrocyte beta-adrenergic receptor.
    Durieu-Trautmann O; Delavier-Klutchko C; Vauquelin G; Strosberg AD
    J Supramol Struct; 1980; 13(4):411-9. PubMed ID: 6112288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, binding affinity and selectivity of new beta 1- and beta 2-adrenoceptor blockers.
    Brizzi V; Francioli M; Brufani M; Filocamo L; Bruni G; Massarelli P
    Farmaco; 1999; 54(11-12):713-20. PubMed ID: 10668169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-specific alterations in receptor binding affinity associated with solubilization of turkey erythrocyte membrane beta adrenergic receptors.
    Pike LJ; Lefkowitz RJ
    Mol Pharmacol; 1978 Mar; 14(2):370-5. PubMed ID: 25377
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioligand binding studies with 3-(4-(2-hydroxy-3-((1, 1-dimethylethyl)-amino)-propoxy)-phenyl)-7-methoxy-2-methyl- 1(2H)-isoquinolinone (HI-42), a new cardioselective beta-adrenoceptor blocker with long-lasting effects in vivo.
    Jackisch R; Lederle M; Hertting G
    Arzneimittelforschung; 1985; 35(1A):237-40. PubMed ID: 2859028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of radiolabelled ligands with specific receptors: an analysis.
    Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
    Membr Cell Biol; 2000; 13(5):667-85. PubMed ID: 10987390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions in beta-adrenergic receptor interactions with the magnesium-guanine nucleotide coupling proteins in turkey erythrocyte and S49 lymphoma membranes.
    Vauquelin G; Cech SY; André C; Strosberg AD; Maguire ME
    J Cyclic Nucleotide Res; 1982; 8(3):149-62. PubMed ID: 6300206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.